Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by greenupon Sep 13, 2018 9:11am
46 Views
Post# 28610925

RE:APH FAILLING to 2th behind the USA version of WEED : CWEB

RE:APH FAILLING to 2th behind the USA version of WEED : CWEBDont pump garbage here, this is APH board!

BTW wait until that midget from Trumps team cracks on them lol 



PaolusPolis wrote:

WOW

Charlotte Web (Cweb) is the Canopy (weed) of the USA, but 1/20th of the WEED valuation... 5x bagger over MONTHS (TLRY style), look for yourselves.

They had 17 millions NET PROFITS 2017, and going on 36 MILLIONS in 2018, THIS IS far better than CANOPY(WEED) AND TILRAY ( TLRY) COMBINED

- Current cash position (on hand) is 100 millions +;
- FY 2018 should lead around 30 millions profits w/ over 100 millions of sales;
- Current cash will generate value and significant distribution channel will widen - probably combined with agressive acquisition;
- They are leading in the market and have a prooven track record of products line capable of curing several desease / stability in the composition;
- Trump administration supported CBD product, enhancing political and social acceptance, which should lead to faster market growth;
- The brothers above the venture are world class manager and knows very wealthy family (did previous JV w/ somes of the top 100 family fortunes in the world) that will surely invest fews hundred of millions over a first mover, capitalized, profitable and aggressive player that has their trust, in the very promising CBD market.

With a 20x P/E ratios, (excluding THC focused company like Weed,acb,tlry,etc) who get a 100x P/E value of 2020 projection..., this company valuation should stands at 2 billions. Which is currently x10 from current share price.

Cut it from 33% to suggest the hype is lower in CBD and it's a USA stock (legal risk on a federal level), I come at 90$ price target.

Finally, you gotta acknoledge that a part from Aphria.... all of theses (TLRY,WEED,ACB,etc) are NOT generating profit, and Charlottes had 17 millions in 2017, aiming at 30+ in 2018... this is HUGE if you analysis the numbers for what they are as of today.

Thanks


Read more at https://www.stockhouse.com/companies/bullboard?symbol=c.cweb&postid=28581200#82gja3kyAjCxYhYJ.99


Bullboard Posts